Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Clinical Research
Clean Genome E.coli – Improved Production
Less is Better - Scarab Genomics bioengineered Clean Genome® E. coli by removing over 15% of the K-12 genome, providing enhanced genetic stability, final products free from insertion sequences (IS), and easier downstream purification away from bacterial components, including endotoxin.
Monitoring Antigen-specific T Cell Immunity by ELISPOT
Cellular Technology Limited (CTL). T and B lymphocytes can each generate immune responses to specific antigens. The resulting immunity helps in the prevention of infectious diseases and in rejection of cancer cells.
Engage Sites and Build Study Visiblity Through Good Effective Communication Practices
By Clinical Performance Partners, Inc. The frenzy of managing the many details of clinical trials often leads sponsors, contract research organizations (CROs), and investigative sites to let go of a key performance driver – maintaining effective communication.
Contextual Cellular Analysis Powers Pharmaceutical and Clinical Research
By Beckman Coulter. Cell-based analysis of potential therapeutic targets and vaccines provides researchers with the high level data required to make informed decisions about the function and efficacy of their compounds.
Comparative Effectiveness Research in the Real World
By Richard Gliklich and Christina DeFilippo Mack. The cost of healthcare in the United States has grown from eight percent of the US economy in 1975 to 16 percent of GDP.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.